Clinical pharmacology and therapeutic applications of the new oral converting enzyme inhibitor, enalapril.
Riley
L J
LJ
Vlasses
P H
PH
Ferguson
R K
RK
D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents / Q000627:therapeutic use; D002216:Captopril / Q000627:therapeutic use; D004151:Dipeptides / Q000378:metabolism / Q000494:pharmacology* / Q000627:therapeutic use; D004656:Enalapril; D006333:Heart Failure / Q000188:drug therapy; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D006929:Hyperaldosteronism / Q000188:drug therapy; D006973:Hypertension / Q000188:drug therapy; D007700:Kinetics; D009842:Oligopeptides / Q000494:pharmacology*; D012083:Renin / Q000097:blood; D013722:Teprotide
D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D004151:Dipeptides; D009842:Oligopeptides; D004656:Enalapril; D002216:Captopril; D013722:Teprotide; D012083:Renin